The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
Description
Since the beginning of the COVID-19 pandemic, there has been an overall improvement in patient mortality. However, haematological malignancy patients continue to experience significant impacts from COVID-19, including high rates of hospitalization
